Literature DB >> 9739380

Conservative treatment of anorectal tumors.

J Kovarik1, V H Svoboda, B Higgins.   

Abstract

PURPOSE: To evaluate the results of interstitial radiotherapy of anorectal tumors. PATIENTS AND METHODS: From 1972 to 1993, one of the authors treated 45 patients by an interstitial implant for anorectal tumors. Of these, 33 patients suffered from primary tumors, 19 from squamous carcinoma, 2 from basaloid carcinoma of the anus and the other 12 from primary adenocarcinoma of the rectum. Of 12 patients treated for local recurrence, 10 had adenocarcinoma and 2 squamous cell carcinoma. Of the 33 patients with primary tumors, 27 received a course of external-beam radiotherapy before the implant. The median follow-up was 35 months.
RESULTS: Local response depended on the tumor volume treated. All 21 anal tumors showed complete response, 5 patients developed local recurrence and 4 distant metastases: 3 died from their disease. Of 12 rectal adenocarcinomas, 9 responded completely, 4 patients developed local recurrence and 4 distant metastases; 6 died from active disease. In the last group of 12 patients who were treated for recurrent tumors, 7 responded completely. One patient developed local recurrence and 9 distant metastases, only 4 are alive.
CONCLUSIONS: A combination of external-beam and interstitial radiotherapy is a relatively simple, non-mutilating, but well-tolerated and very effective method of treatment for early carcinoma of the lower rectum and anus.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9739380     DOI: 10.1007/bf03038561

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  17 in total

1.  Delayed complications in colo-rectal carcinoma treated by combination radiotherapy and 5-fluorouracil--Eastern Cooperative Oncology Group (E.C.O.G.) pilot study.

Authors:  C E Danjoux; G E Catton
Journal:  Int J Radiat Oncol Biol Phys       Date:  1979-03       Impact factor: 7.038

2.  Definitive treatment of extensive anorectal carcinoma by external and interstitial irradiation.

Authors:  A A Puthawala; A M Syed; T C Gates; C McNamara
Journal:  Cancer       Date:  1982-11-01       Impact factor: 6.860

3.  Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.

Authors:  H Bartelink; F Roelofsen; F Eschwege; P Rougier; J F Bosset; D G Gonzalez; D Peiffert; M van Glabbeke; M Pierart
Journal:  J Clin Oncol       Date:  1997-05       Impact factor: 44.544

4.  Chemotherapy and radiation therapy for anal carcinoma. Survival and late morbidity.

Authors:  G Tanum; K Tveit; K O Karlsen; M Hauer-Jensen
Journal:  Cancer       Date:  1991-05-15       Impact factor: 6.860

5.  Radiotherapy for anal cancer: experience from 1979-1987.

Authors:  L L Hughes; T A Rich; L Delclos; J A Ajani; R G Martin
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-12       Impact factor: 7.038

6.  Interstitial curietherapy in the conservative treatment of anal and rectal cancers.

Authors:  J Papillon; J F Montbarbon; J P Gerard; J L Chassard; J M Ardiet
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-12       Impact factor: 7.038

Review 7.  Anal cancer: multimodal therapy.

Authors:  P M Schlag; M Hünerbein
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

8.  Epidermoid carcinoma of the anal canal: treatment by combined radiation and chemotherapy.

Authors:  G G Grabenbauer; I H Schneider; F P Gall; R Sauer
Journal:  Radiother Oncol       Date:  1993-04       Impact factor: 6.280

9.  Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C.

Authors:  B J Cummings; T J Keane; B O'Sullivan; C S Wong; C N Catton
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-10       Impact factor: 7.038

10.  Carcinoma of the anal canal.

Authors:  R J Myerson; S J Shapiro; D Lacey; M Lopez; E Birnbaum; J Fleshman; R Fry; I Kodner
Journal:  Am J Clin Oncol       Date:  1995-02       Impact factor: 2.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.